News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
798,193 Results
Type
Article (49344)
Company Profile (489)
Press Release (748348)
Multimedia
Podcasts (155)
Webinars (28)
Section
Business (255202)
Career Advice (2733)
Deals (38828)
Drug Delivery (161)
Drug Development (87159)
Employer Resources (187)
FDA (17825)
Job Trends (16585)
News (377290)
Policy (36063)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2746)
Academic (1)
Accelerated approval (59)
ADA (48)
Adcomms (37)
Allergies (207)
Alliances (54020)
ALS (242)
Alzheimer's disease (1987)
Antibody-drug conjugate (ADC) (576)
Approvals (18265)
Artificial intelligence (807)
ASCO (340)
Autoimmune disease (376)
Automation (67)
Bankruptcy (404)
Best Places to Work (12293)
BIO (78)
BIOSECURE Act (23)
Biosimilars (254)
Biotechnology (310)
Bladder cancer (215)
Brain cancer (83)
Breast cancer (845)
Cancer (6691)
Cardiovascular disease (559)
Career advice (2322)
Career pathing (51)
CAR-T (381)
CDC (68)
Celiac Disease (3)
Cell therapy (1048)
Cervical cancer (57)
Clinical research (76022)
Collaboration (2425)
Commercialization (1)
Company closure (7)
Compensation (1591)
Complete response letters (112)
COVID-19 (2962)
CRISPR (128)
C-suite (1360)
Cystic fibrosis (165)
Data (8980)
Decentralized trials (3)
Denatured (37)
Depression (200)
Dermatology (105)
Diabetes (708)
Diagnostics (7534)
Digital health (68)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (399)
Drug pricing (238)
Drug shortages (36)
Duchenne muscular dystrophy (328)
Earnings (98862)
Editorial (77)
Employer branding (24)
Employer resources (166)
Events (132987)
Executive appointments (1218)
FDA (22056)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (1983)
Gene editing (274)
Generative AI (69)
Gene therapy (834)
GLP-1 (1261)
Government (5087)
Grass and pollen (8)
Guidances (425)
Healthcare (20364)
Hematology (197)
HIV (95)
Huntington's disease (71)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (119)
Immunology and inflammation (355)
Immuno-oncology (118)
Indications (227)
Infectious disease (3355)
Inflammatory bowel disease (241)
Inflation Reduction Act (15)
Influenza (150)
Intellectual property (333)
Interviews (505)
IPO (17840)
IRA (57)
Job creations (4642)
Job search strategy (1898)
JPM (68)
Kidney cancer (23)
Labor market (116)
Layoffs (681)
Leadership (50)
Legal (9064)
Liver cancer (109)
Longevity (37)
Lung cancer (879)
Lymphoma (490)
Machine learning (68)
Management (66)
Manufacturing (1253)
Marketing (7)
MASH (229)
Medical affairs (1)
Medical device (15060)
Medtech (15251)
Mergers & acquisitions (22337)
Metabolic disorders (1825)
mRNA (269)
Multiple sclerosis (211)
NASH (22)
Neurodegenerative disease (526)
Neuropsychiatric disorders (125)
Neuroscience (3773)
Neurotech (1)
NextGen: Class of 2026 (7223)
Non-profit (4696)
Now hiring (84)
Obesity (861)
Opinion (365)
Ovarian cancer (249)
Pain (285)
Pancreatic cancer (373)
Parkinson's disease (424)
Partnered (39)
Patents (671)
Patient recruitment (830)
Peanut (71)
People (65407)
Pharmaceutical (78)
Pharmacy benefit managers (38)
Phase 1 (23720)
Phase 2 (33443)
Phase 3 (24963)
Pipeline (10378)
Policy (381)
Postmarket research (2731)
Preclinical (10059)
Press Release (71)
Prostate cancer (354)
Psychedelics (74)
Radiopharmaceuticals (378)
Rare diseases (1313)
Real estate (6797)
Recruiting (77)
Regulatory (28183)
Reports (60)
Research institute (2553)
Resumes & cover letters (442)
Rett syndrome (47)
RNA editing (27)
RSV (99)
Schizophrenia (198)
Series A (343)
Series B (249)
Service/supplier (14)
Sickle cell disease (132)
Special edition (32)
Spinal muscular atrophy (182)
Sponsored (50)
Startups (4199)
State (2)
Stomach cancer (20)
Supply chain (143)
Tariffs (104)
The Weekly (115)
Vaccines (1285)
Venture capital (137)
Weight loss (577)
Women's health (142)
Worklife (25)
Date
Today (123)
Last 7 days (482)
Last 30 days (2040)
Last 365 days (32228)
2026 (17849)
2025 (31961)
2024 (37264)
2023 (42270)
2022 (53606)
2021 (58245)
2020 (56750)
2019 (49624)
2018 (37640)
2017 (35250)
2016 (35176)
2015 (41188)
2014 (35144)
2013 (30030)
2012 (32011)
2011 (32454)
2010 (30410)
Location
Africa (891)
Alabama (103)
Alaska (7)
Arizona (389)
Arkansas (16)
Asia (46260)
Australia (7658)
California (14624)
Canada (4079)
China (1638)
Colorado (627)
Connecticut (639)
Delaware (448)
Europe (103191)
Florida (2201)
Georgia (466)
Hawaii (4)
Idaho (67)
Illinois (1220)
India (109)
Indiana (670)
Iowa (25)
Japan (625)
Kansas (141)
Kentucky (56)
Louisiana (63)
Maine (91)
Maryland (1727)
Massachusetts (10699)
Michigan (406)
Minnesota (808)
Mississippi (6)
Missouri (165)
Montana (36)
Nebraska (31)
Nevada (158)
New Hampshire (91)
New Jersey (3875)
New Mexico (34)
New York (3857)
North Carolina (1932)
North Dakota (11)
Northern California (7344)
Ohio (451)
Oklahoma (26)
Oregon (46)
Pennsylvania (2871)
Puerto Rico (33)
Rhode Island (53)
South America (1322)
South Carolina (91)
South Dakota (2)
Southern California (5780)
Tennessee (235)
Texas (2356)
United States (52031)
Utah (440)
Vermont (2)
Virginia (362)
Washington D.C. (88)
Washington State (1184)
West Virginia (4)
Wisconsin (156)
Wyoming (2)
798,193 Results for "lannett company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lannett Company, Lanexa Biologics and Sunshine Lake Pharma announce FDA Approval of LANGLARA™ an Interchangeable Biosimilar of Lantus® (insulin glargine)
May 4, 2026
·
5 min read
Press Releases
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
June 30, 2026
·
2 min read
Press Releases
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Support the Company’s Advancement Toward Commercialization
June 8, 2026
·
2 min read
Press Releases
Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK
June 11, 2026
·
4 min read
Press Releases
Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd
July 6, 2026
·
2 min read
Business
Lannett Company, Inc. Enters Into Restructuring Support Agreement
Lannett Company, Inc. (OTCMKTS: LCIN) (the “Company” or “Lannett”) today announced that, together with certain of its subsidiaries (collectively with the Company, as applicable, the “Company Parties”), it has entered into a Restructuring Support Agreement (the “RSA”) with holders of more than 80% of its 7.750% senior secured notes due 2026.
May 1, 2023
·
7 min read
Press Releases
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
May 12, 2026
·
3 min read
Deals
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS
Lannett Company, Inc. (LCI) (“Lannett” or “the Company”) today announced that it received a written notice from the New York Stock Exchange (“NYSE”) dated April 19, 2023, notifying the Company that the NYSE will commence proceedings to delist the Company’s common stock from the NYSE.
April 20, 2023
·
3 min read
Press Releases
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
June 19, 2026
·
6 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
1 of 79,820
Next
